A Low Peeling, Fast and Easy Approach for Protein O-linked Glycan Analysis

Significance of the Topic

Protein O-linked glycosylation influences many aspects of glycoprotein function, including stability, activity, and immunogenicity. Characterizing O-glycan structures is crucial in biopharmaceutical development and quality control of recombinant glycoprotein drugs. A practical, low-peeling method enables accurate profiling of O-glycans, supporting consistency in manufacturing and facilitating research in immunology and cellular biology.

Objectives and Overview of the Study

This study aimed to establish a simplified workflow for releasing, labeling, and analyzing protein O-linked glycans that minimizes peeling side-products and accelerates sample preparation. By integrating the S-Bio EZGlyco™ O-Glycan Prep kit with the Shimadzu Nexera-i MT platform and RF-20A fluorescence detection, the work demonstrates high sensitivity and reproducibility in glycan profiling, using fetuin as a model glycoprotein.

Methodology and Instrumentation

The method employs the EZGlyco™ O-Glycan Prep kit for O-glycan release, enrichment, 2-AB fluorescent labeling, and cleanup in under five hours. Key reagents (acetic acid, acetonitrile, methanol) are added by the user. Labeled glycans are analyzed by:

• LC-Fluorescence: Shimadzu Nexera-i MT with Shim-pack GIST-HP Amide column (1.9 µm, 150 × 2.1 mm) at 45 °C, 0.25 mL/min; mobile phase A: 100 mM ammonium formate, B: acetonitrile; gradient from 80% to 50% B; detection at Ex 330 nm/Em 420 nm.
• LC-MS/MS: Shimadzu Nexera-X2 paired with LCMS-9030 Q-TOF, heated ESI interface (±4 kV), scan range 50–1500 m/z, MS/MS for structural confirmation.

Main Results and Discussion

Chromatographic separation of 2-AB labeled O-glycans from fetuin yielded four major peaks. MS/MS data confirmed the expected glycan compositions (GalNAc, GlcNAc, Gal, NeuAc) with minimal peeling by-products (<3% relative abundance). Injection-to-injection reproducibility was excellent, with peak area RSDs below 2% and retention time RSDs below 0.2%, demonstrating robust performance for routine analysis.

Benefits and Practical Applications of the Method

The streamlined workflow reduces sample preparation time to less than five hours and significantly lowers side-reaction products. This enhances quantification accuracy and throughput for:

• Biopharmaceutical quality control of recombinant glycoproteins.
• Research in glycoimmunology and cell signaling.
• Comparative glycomics in biomarker discovery.

Future Trends and Potential Applications

Advancements may include automated sample handling to further increase throughput, integration with ultra-high-resolution MS for deeper glycan structural elucidation, and adaptation to multiplexed fluorescent labels. The method could also support on-line glyco-profiling in bioprocess monitoring and linked omics studies.

Conclusion

The combined EZGlyco™ kit and Shimadzu Nexera-i MT/LCMS-9030 platform provides a fast, reliable, and low-peeling approach for O-glycan analysis. Its reproducibility and simplicity make it well suited for both research and industrial glycoprotein characterization.

References

1. Application News No. AD-0234A, Shimadzu Corporation.
2. Preparation and LC-MS Analysis of Procainamide-Labeled O-Glycans Using EZGlyco™ O-Glycan Prep Kit, S-Bio.